Loading clinical trials...
Loading clinical trials...
Efficacy of Peripheral Nerve Blocks for Episodic Migraine Treatment and Prophylaxis
Conditions
Interventions
Bupivacaine HCl 0.5% Injectable Solution
Methylprednisolone 40 MG Injection
Locations
1
United States
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Start Date
July 10, 2023
Primary Completion Date
February 1, 2027
Completion Date
July 1, 2027
Last Updated
March 6, 2026
NCT06248671
NCT03432286
NCT05207865
NCT06004388
NCT06155123
NCT04936061
Lead Sponsor
Mayo Clinic
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions